Eledon Pharmaceuticals Inc.

News & Events

Press Releases

In The Media

1. Updated Data from Eledon Pharmaceuticals' Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

   GlobeNewswire JUL 17, 2025 4:01 PM EDT
   IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon&#x...
   READ ARTICLE

2. Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

   GlobeNewswire JUL 9, 2025 8:30 AM EDT
   LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics (“Sernovaȁ...
   READ ARTICLE

3. Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

   GlobeNewswire JUN 25, 2025 4:01 PM EDT
   IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon&#x...
   READ ARTICLE

4. Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

   GlobeNewswire MAY 14, 2025 4:01 PM EDT
   On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth ...
   READ ARTICLE

5. Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

   GlobeNewswire MAR 20, 2025 4:01 PM EDT
   Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a ge...
   READ ARTICLE

6. Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

   GlobeNewswire MAR 4, 2025 4:05 PM EST
   IRVINE, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon&#...
   READ ARTICLE

7. Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

   GlobeNewswire FEB 7, 2025 10:00 AM EST
   Patient treated in procedure, conducted at Mass General Transplant Center and in collaboration wi...
   READ ARTICLE

8. Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

   GlobeNewswire JAN 29, 2025 4:05 PM EST
   IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon&#x...
   READ ARTICLE

9. Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

   GlobeNewswire JAN 13, 2025 7:00 AM EST
   Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four...
   READ ARTICLE

10. Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

    GlobeNewswire NOV 12, 2024 4:01 PM EST
    Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months...
    READ ARTICLE